Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 3, 1997, Pages 311-314

  Dourakis, Spyros P ^a   Sinani, Chrisanthi ^a   Deutsch, Melanie ^a   Dimitriaclou, Evangelia ^a   Hadziyannis, Stephanos J ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Cholestasis; Obstructive jaundice; Paraneoplastic syndromes; Renal cell carcinoma; Stauffer's syndrome

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN GLUCURONIDE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; CASE REPORT; CHOLESTASIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEMATURIA; HUMAN; KIDNEY CARCINOMA; LIVER DYSFUNCTION; LIVER METASTASIS; MALE; NEPHRECTOMY; OBSTRUCTIVE JAUNDICE; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PRURITUS;

EID: 0030936066     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199703000-00018     Document Type: Article

References (27)

1. Kaaden R, Zwack K, Wienbeck M, Klotz E: Ikterische cholestase als frühsymptom bei morbus Hodgkin. Dtsch Med Wschr 1990, 115:1670-1673.
2. Perera DR, Greene ML, Femster LF: Cholestasis associated with extrabiliary Hodgkin's disease. Gastroenterology 1974, 67:680-685.
3. Watterson J, Priest JR: Jaundice as a paraneoplastic phenomenon in a T-cell lymphoma. Gastroenterology 1989, 97:1319-1321.
4. Warren MM, Keblis PP, Utz DC: The changing concept of hypernephroma. J Urol 1976, 101:376-378.
5. Boxer RJ, Waisman J, Lieber MM, et al.: Nonmetastatic hepatic dysfunction associated with renal carcinoma. J Urol 1978, 119:468-471.
6. Chisholm GD, Roy RR: The systemic effects of malignant renal tumours. Br J Urol 1971, 43:687-700.
7. Cronin RE, Kaehny WD, Miller PD, et al.: Renal cell carcinoma: unusual systemic manifestations. Medicine 1976, 55: 291-311.
8. Ramos CV, Taylor HB: Hepatic dysfunction associated with renal carcinoma. Cancer 1972, 29:1287-1292.
9. Walsh PN, Kissane JM: Nonmetastatic hypernephroma with reversible hepatic dysfunction. Arch Intern Med 1968, 122:214-220.
10. Utz DC, Warren MM, Gregg JA, et al.: Reversible hepatic dysfunction associated with hypernephroma. Mayo Clin Proc 1970, 45:161-169.
11. Stauffer MH: Nephrogenic hepatosplenomegaly. Gastroenterology 1961, 40:694.
12. Lemmon WT, Holland PV, Holland JM: The hepatopathy of hypernephroma. Am J Surg 1965, 110:487-491.
13. Chang S-Y, Yu D-S, Sherwood ER, et al.: Inhibitory effects of suramin on a human renal cell carcinoma line, causing nephrogenic hepatic dysfunction. J Urol 1992, 147:1147-1150.
14. Tsukamoto T, Kumamoto Y, Miyao N, et al.: Interleukin 6 in renal cell carcinoma. J Urol 1992, 148:1778-1781.
15. Shopman KH, Downong SW, Bradford HA: Hypernephroma presenting as fever of unknown origin associated with elevated alkaline phosphatase levels. J Urol 1963, 89:160-163.
16. Stolbach LL, Krant MJ, Fishman WH: Ectopic production of an alkaline phosphatase isoenzyme in patients with cancer. N Engl J Med 1969, 281:757-762.
17. Durocher JR: Alkaline phosphatase and hypernephroma. N Engl J Med 1969, 281:1369-1370.
18. Aoyagi T, Mori I, Ueyama Y, et al.: Sinusoidal dilatation of the liver as a paraneoplastic manifestation of renal cell carcinoma. Hum Pathol 1989, 20:1193-1197.
19. Chagnac A, Gal R, Kimche D, et al.: Liver granulomas: a possible paraneoplastic manifestation of hypernephroma. Am J Gastroenterol 1985, 12:989-992.
20. Laraki R, Bougaran JA, Vallancien G, et al.: Syndrome de Stauffer dû a un hématome intrakystique rénal bénin. Presse Med 1992, 21:472-474.
21. Vermillion SE, Morlock CG, Bartholomew LG, et al.: Nephrogenic hepatic dysfunction secondary to tumefactive xanthogranulomatous pyelonephritis. Ann Surg 1970, 171:130-136.
22. Summerskill WHJ, Shorter RG: Progressive hepatic failure: its association with an undifferentiated renal tumor. Arch Intern Med 1967, 120:81-84.
23. Jakobovits AW, Crimmins FB, Sherlock S, et al.: Cholestasis as a paraneoplastic manifestation of carcinoma of the kidney. Aust NZ J Med 1981, 11:64-67.
24. Fang JW, Lau JY, Wu PC, et al.: Fulminant hepatic failure in nonmetastatic renal cell carcinoma. Dig Dis Sci 1992, 37:474-477.
25. Sherlock S, Deolley J: Cholestasis. In Diseases of the Liver and Biliary System, 9th edn. Oxford: Blackwell Scientific; 1993:214-235.
26. Strickland RC, Schenker S: The nephrogenic hepatic dysfunction syndrome: a review. Am J Dig Dis 1977, 22:49-55.
27. Cooper DS: Antithyroid drugs. N Engl J Med 1984, 311:1353-1362.